Amalgamated Bank Sells 2,662 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Amalgamated Bank cut its stake in shares of Henry Schein, Inc. (NASDAQ:HSICGet Rating) by 5.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 47,995 shares of the company’s stock after selling 2,662 shares during the quarter. Amalgamated Bank’s holdings in Henry Schein were worth $4,185,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Keene & Associates Inc. increased its holdings in shares of Henry Schein by 2.7% during the first quarter. Keene & Associates Inc. now owns 4,405 shares of the company’s stock valued at $384,000 after acquiring an additional 115 shares in the last quarter. State of Michigan Retirement System increased its holdings in shares of Henry Schein by 0.3% during the first quarter. State of Michigan Retirement System now owns 38,360 shares of the company’s stock valued at $3,345,000 after acquiring an additional 121 shares in the last quarter. Cambridge Investment Research Advisors Inc. increased its holdings in Henry Schein by 2.4% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company’s stock worth $459,000 after buying an additional 122 shares in the last quarter. Stephens Inc. AR increased its holdings in Henry Schein by 5.8% in the 4th quarter. Stephens Inc. AR now owns 2,230 shares of the company’s stock worth $173,000 after buying an additional 123 shares in the last quarter. Finally, CIBC Asset Management Inc increased its holdings in Henry Schein by 1.0% in the 1st quarter. CIBC Asset Management Inc now owns 13,079 shares of the company’s stock worth $1,140,000 after buying an additional 133 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.

Henry Schein Stock Down 1.6 %

HSIC stock opened at $69.07 on Thursday. Henry Schein, Inc. has a twelve month low of $69.03 and a twelve month high of $92.68. The company has a quick ratio of 0.95, a current ratio of 1.83 and a debt-to-equity ratio of 0.18. The stock has a market cap of $9.40 billion, a P/E ratio of 14.82, a PEG ratio of 1.92 and a beta of 0.76. The business’s 50-day moving average price is $74.91 and its 200-day moving average price is $80.69.

Henry Schein (NASDAQ:HSICGet Rating) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported $1.16 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.16. Henry Schein had a return on equity of 15.56% and a net margin of 5.11%. The firm had revenue of $3.03 billion for the quarter, compared to analysts’ expectations of $3.12 billion. During the same period in the previous year, the firm earned $1.11 EPS. The business’s quarterly revenue was up 2.1% on a year-over-year basis. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.85 EPS for the current year.

Henry Schein declared that its board has approved a share buyback program on Thursday, August 18th that allows the company to repurchase $400.00 million in outstanding shares. This repurchase authorization allows the company to repurchase up to 4% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s management believes its shares are undervalued.

Analyst Ratings Changes

Several research firms recently commented on HSIC. Stifel Nicolaus reduced their price objective on Henry Schein from $90.00 to $80.00 in a report on Friday, June 17th. Evercore ISI reduced their price objective on Henry Schein to $83.00 in a report on Tuesday, August 9th. Credit Suisse Group reduced their price objective on Henry Schein from $100.00 to $90.00 and set an “outperform” rating for the company in a report on Wednesday, August 3rd. Barrington Research dropped their target price on Henry Schein from $102.00 to $99.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 3rd. Finally, Piper Sandler dropped their target price on Henry Schein from $100.00 to $96.00 in a research report on Tuesday, August 2nd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $85.89.

Henry Schein Profile

(Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.